Award Notices

Heinz Lehmann Award

For Outstanding Contributions to Neuropsychopharmacology

Sponsored by Otsuka-Lundbeck Alliance

The Heinz Lehmann Award is designed to recognize the outstanding contributions and distinguished career by a CCNP member in the field of research in neuropsychopharmacology in Canada. The Award consists of $2,000 honorarium and a suitably engraved plaque. The Heinz Lehmann Award shall be presented annually for work done primarily in Canada by Canadian scientists. Exceptionally, if there is no qualified nominee in the view of the Awards Committee, the award will not be given.

Eligibility shall include individuals from academic institutions, foundations, governmental, industrial and research organizations, regardless of age or sex. The decision of the Awards Committee shall be based on originality and uniqueness of approach to clinical or laboratory research that had led to new, significant neuropsychopharmacological knowledge or concepts, or to the development of new therapeutic agents for the treatment of mental diseases. This should be evidenced by contributions based either on a specific piece of research or on a large body of neuropsychopharmacological research done over a period of years. In assessing individual publications, the committee will consider citation history, but not to the exclusion of other information. For works by multiple authors, the particular contribution of the award nominee must be clearly specified. The Awardee is expected to give a lecture based on their research at the Annual Meeting of the CCNP, and is encouraged to contribute a manuscript based on the lecture to the CCNP official journal, the Journal of Psychiatry & Neuroscience, no later than six months after the lecture.

Nomination for 2024 Heinz Lehmann Award

The names of nominees should be received by Dr. Daniel Mueller by June 28, 2024. Supporting documentation must be received by July 14, 2024. For each award, this documentation shall consist of:

  1. A completed Heinz Lehmann Award checklist, signed by the nominee.
  2. A maximum two-page summary (12 point font and 1 inch margins) prepared by the nominee describing the nominee’s contributions, distinguishing career accomplishments, importance of the nominee’s work in furthering the field of Neuropsychopharmacology including an EDI statement.
  3. Up to 5 manuscripts or reprints considered by the sponsor to be pertinent to the nomination and which highlight the nominee’s work.
  4. The nominee’s curriculum vitae (5-page NIH biosketch format).
Formal presentation of the Award will be made to the recipient during the Annual Meeting of the College.

Note: The Heinz Lehmann Research Award may be given for basic research or clinical research in alternate years. The 2024 Award will be presented for clinical research.

Please send the name of the nominee and a short supporting letter to:

Dr. Daniel Mueller
CCNP President

Please send one copy of the above electronically to Dr. Mueller at daniel.mueller@camh.ca and one copy to the CCNP Secretariat at trudyvalliere4@gmail.com.

See the previous recipients of awards.

Young Investigator Award

For Outstanding Contributions to Neuropsychopharmacology by a Young Investigator

Sponsored by Otsuka-Lundbeck Alliance

The Young Investigator Award is designed to recognize outstanding contributions in the field of research in neuropsychopharmacology by a CCNP member who is a young basic scientist or clinical investigator in Canada. Applications will be judged primarily on the basis of the candidate’s work as an independent investigator. The Award consists of a $2,000 honorarium and a suitably engraved plaque. The Young Investigator Award shall be presented annually for work done primarily in Canada by Canadian scientists, unless there is, in the view of the Awards Committee, no qualified nominee.

The major selection criterion is that the candidate be actively engaged in high quality neuropsychopharmacological research in Canada. There is no restriction concerning the field in which nominees have obtained their doctoral degree, but not more than 12 years (for this competition only) should have elapsed since the completion of their post-doctoral or residency training by July of the year of presentation. It is not required that the candidates be members of the College or have an academic appointment. The Awardee is expected to give a lecture based on their research at the Annual Meeting of the CCNP, and encouraged to contribute a manuscript based on the lecture to the CCNP official journal, the Journal of Psychiatry & Neuroscience, no later than six months after the lecture.

Nomination for 2024 CCNP Young Investigator Award

The names of nominees should be received by Dr. Daniel Mueller by June 28, 2024. Supporting documentation must be received by July 14, 2024. For each award, this documentation shall consist of:

  1. A completed Young Investigator Award checklist, signed by the nominee.
  2. A two-page summary (12 point font and 1 inch margins) prepared by the nominee describing the nominee’s work and its importance in furthering the field of Neuropsychopharmacology including an EDI statement.
  3. Up to 5 manuscripts or reprints considered by the sponsor to be pertinent to the nomination and which highlight the nominee’s work.
  4. The nominee’s curriculum vitae (5-page NIH biosketch format).

Formal presentation of the Award will be made to the recipient during the Annual Meeting of the College.

Note: The Young Investigator Award is given for basic research or clinical research in alternate years. The 2024 Award will be presented for basic research.

Please send the name of the nominee and a short supporting letter to:

Dr. Daniel Mueller
CCNP President

Please send one copy of the above electronically to Dr. Mueller at daniel.mueller@camh.ca and one copy to the CCNP Secretariat at trudyvalliere4@gmail.com.

See the previous recipients of awards.

CCNP Innovations in Neuropsychopharmacology Research Award

For Outstanding Innovations in Neuropsychopharmacology by an Individual or Group

Sponsored by Otsuka-Lundbeck Alliance

The Innovations in Neuropsychopharmacology Research Award is designed to recognize innovative research in neuropsychopharmacology by CCNP members at the level of independent investigators. The Award consists of $2,000 and a suitably engraved plaque. The Innovations in Neuropsychopharmacology Award shall be presented annually for work done primarily in Canada by Canadian scientists. Exceptionally, if there is no qualified nominee in the view of the Awards Committee, the award will not be given.

The decision of the Awards Committee will be based solely on the outstandingly innovative nature of the work by an individual or a group, as demonstrated by a single piece of research or by a body of work contributed over a number of years. Since science, by its nature, generates novel findings, the Awards Committee will seek more than the reporting of novel data. In particular, the committee will seek to identify contributions that have had a major impact in the field, for example: the introduction of a new research tool, or findings that lead to new avenues of research or successfully challenge the prevailing consensus. In assessing individual publications, the committee will consider citation history, but not to the exclusion of other information. For works by multiple authors, the particular contribution of the award nominee or nominated team (typically no more than 2 or 3) must be clearly specified. The Awardee(s) is/are expected to give a lecture based on their research at the Annual Meeting of the CCNP, and is encouraged to contribute a manuscript, based on the lecture, to the CCNP official journal, the Journal of Psychiatry & Neuroscience, not later than six months after the lecture.

Nomination for 2024 Innovations in Neuropsychopharmacology Research Award

The names of nominees should be received by Dr. Daniel Mueller by June 28, 2024. Supporting documentation must be received by July 14, 2024. For each award, this documentation shall consist of:

  1. A completed CCNP Innovations Award checklist, signed by the nominee.
  2. A maximum two-page summary (12 point font and 1 inch margins) prepared by the nominee describing the nominee’s work and what makes it innovative and influential, furthering the field of Neuropsychopharmacology, including an EDI statement.
  3. Up to 5 manuscripts or reprints considered by the sponsor to be pertinent to the nomination and which highlight the nominee’s work.
  4. The nominee’s curriculum vitae (5-page NIH biosketch format).

Formal presentation of the Award will be made to the recipient during the Annual Meeting of the College.

Note: The Innovations in Neuropsychopharmacology Research Award may be given for basic research or clinical research in alternate years. The 2024 Award will be presented for clinical research.

Please send the name of the nominee and a short supporting letter to:

Dr. Daniel Mueller
CCNP President

Please send one copy of the above electronically to Dr. Mueller at daniel.mueller@camh.ca and one copy to the CCNP Secretariat at trudyvalliere4@gmail.com.

See the previous recipients of awards.

CCNP Medal

This Award was established to honor a CCNP member for a meritorious career in, and outstanding contribution to, neuropsychopharmacology in Canada as evidenced by their activities in education, administration and/or patient care. Achievement in research is not a necessary criterion for this Award. An outstanding contribution implies achievement at the national or international level, and evidence of novel initiatives.

The Award, which does not have to be awarded each year, consists of a bronze medal engraved with the name of the recipient. Note: CCNP holds the right to not hand out that award in a given year.

Nomination for 2024 CCNP Medal

The names of nominees should be received by Dr. Daniel Mueller by June 28, 2024. Supporting documentation must be received by July 14, 2024. For each award, this documentation shall consist of:

  1. A completed CCNP Medal checklist, signed by the nominee.
  2. A maximum of two-page summary (12 point font and 1 inch margins) prepared by the nominee describing the nominee’s work and its importance in furthering the field of Neuropsychopharmacology, including an EDI statement.
  3. The nominee’s curriculum vitae (5-page NIH biosketch format).
  4. Up to five manuscripts or reprints considered by the sponsor to be pertinent to the nomination and which highlight the nominee’s work.

Formal presentation of the Award will be made to the recipient during the Annual Meeting of the College.

Please send the name of the nominee and a short supporting letter to:

Dr. Daniel Mueller
CCNP President

Please send one copy of the above electronically to Dr. Mueller at daniel.mueller@camh.ca and one copy to the CCNP Secretariat at trudyvalliere4@gmail.com.

See the previous recipients of awards.

Jock Cleghorn Prize

for the Best Poster Presentation

This prize, which will consist of a cheque for $500, will be awarded by the CCNP for the best poster presentation by a research trainee (graduate student or clinical resident or postdoc) at the Annual Meeting of the CCNP. All trainees/students who submit a poster presentation for the Annual Meeting will be eligible for this prize. Those already applying for W.G. Dewhurst travel awards will automatically be considered for the Jock Cleghorn Prize.

The poster presentations will be judged at the Annual Meeting by a committee consisting of at least three members of the CCNP council (or substitute judges to be chosen by the Council from the CCNP membership if needed). Topics on either basic or clinical aspects of neuropsychopharmacology will be considered. The poster should represent research in which the graduate student, postdoc, or resident is the primary investigator. Only the first author of the submitted abstract is eligible for the award. The winner of the award will be announced at the CCNP banquet and in the first Newsletter following the Annual Meeting.

See the previous recipients of awards.

W.G. Dewhurst Travel Awards

The CCNP is making available up to six travel awards for research trainees to attend the Annual Meeting. Each award will be for an amount determined by the CCNP Treasurer. CCNP junior members who are working in Canada or Canadian CCNP junior members working abroad are eligible to receive these travel awards. All applicants should be in good standing with their membership dues. Those who wish to apply for an award should email a completed abstract, together with a letter of support from their research supervisor, to:

Trudy Valliere at trudyvalliere4@gmail.com.

Travel awards will be awarded to those who submit the best abstracts.

See the previous recipients of awards.